Stock listing
BIVA:MIRM Mirum Pharmaceuticals, Inc. Acciones
Mexican listing (BIVA) of Mirum Pharmaceuticals, Inc. · home listing NASDAQ:MIRM
Follow Mirum Pharmaceuticals, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:MIRM
$93.72 USD +0.18 (+0.2%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:MIRM
- Day range
- $91.18 – $95.59 USDNov 6, 2026
- Volume
- 722,713 sharesNov 6, 2026
- Market cap
- $6.09B USDAt the close on Nov 6, 2026 · price × 64.93M shares outstanding
- 52-week range
- $63.23 – $130.00 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $66.43M USDMedian day 644,350 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MIRM · Home | $93.72 USD | +0.18 (+0.2%) | 722,713 | $93.14 | $95.59 | $91.18 | $93.54 | Close on Nov 6, 2026 |
| Frankfurt:08D | €82.00 EUR | -3.497 (-4.1%) | — | €81.53 | €82.59 | €81.06 | €85.50 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:MIRM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $93.72 | +0.18 | +0.2% | $93.14 | $95.59 | $91.18 | 722,713 | |
| $93.54 | -3.43 | -3.5% | $96.72 | $98.97 | $93.33 | 871,300 | |
| $96.97 | +9.94 | +11.4% | $83.13 | $97.26 | $83.13 | 1,153,580 | |
| $87.03 | +1.29 | +1.5% | $85.89 | $88.54 | $85.89 | 635,382 | |
| $85.74 | +0.74 | +0.9% | $85.55 | $86.52 | $83.69 | 522,771 | |
| $85.00 | -1.39 | -1.6% | $85.21 | $87.46 | $84.12 | 673,419 | |
| $86.39 | +0.58 | +0.7% | $86.72 | $88.48 | $84.66 | 591,311 | |
| $85.81 | +0.25 | +0.3% | $85.00 | $86.63 | $84.75 | 535,208 | |
| $85.56 | +2.29 | +2.8% | $83.10 | $85.62 | $82.18 | 563,275 | |
| $83.27 | +2.88 | +3.6% | $81.76 | $83.47 | $81.16 | 429,874 | |
| $80.39 | -2.71 | -3.3% | $82.39 | $83.00 | $80.24 | 788,200 | |
| $83.10 | -0.34 | -0.4% | $83.26 | $84.86 | $82.58 | 420,900 | |
| $83.44 | -1.63 | -1.9% | $85.16 | $85.84 | $82.86 | 646,900 | |
| $85.07 | +2.83 | +3.4% | $82.75 | $85.55 | $82.32 | 633,300 | |
| $82.24 | +2.10 | +2.6% | $80.90 | $82.89 | $80.35 | 417,900 | |
| $80.14 | -2.25 | -2.7% | $82.48 | $82.48 | $79.64 | 462,900 | |
| $82.39 | +2.43 | +3.0% | $82.10 | $83.48 | $81.00 | 605,200 | |
| $79.96 | +0.34 | +0.4% | $78.41 | $81.91 | $78.35 | 975,100 | |
| $79.62 | -6.44 | -7.5% | $86.06 | $87.00 | $79.51 | 762,600 | |
| $86.06 | +0.05 | +0.1% | $87.22 | $88.31 | $81.95 | 1,211,600 | |
| $86.01 | +4.66 | +5.7% | $81.01 | $87.79 | $81.01 | 1,139,700 | |
| $81.35 | +0.71 | +0.9% | $80.31 | $82.20 | $78.63 | 664,300 | |
| $80.64 | +1.39 | +1.8% | $78.79 | $83.13 | $78.39 | 1,020,800 | |
| $79.25 | -2.18 | -2.7% | $81.94 | $81.94 | $77.78 | 1,146,900 | |
| $81.43 | -1.50 | -1.8% | $83.30 | $83.35 | $81.23 | 980,100 | |
| $82.93 | -0.99 | -1.2% | $84.67 | $84.68 | $81.41 | 1,134,000 | |
| $83.92 | -1.56 | -1.8% | $85.42 | $86.17 | $83.68 | 641,800 | |
| $85.48 | -2.06 | -2.4% | $88.85 | $88.85 | $85.36 | 901,200 | |
| $87.54 | -0.42 | -0.5% | $89.04 | $90.31 | $86.51 | 666,800 | |
| $87.96 | -1.74 | -1.9% | $90.00 | $91.25 | $84.71 | 1,236,800 | |
| $89.70 | +0.34 | +0.4% | $89.90 | $90.81 | $88.28 | 763,600 | |
| $89.36 | +0.04 | 0.0% | $89.24 | $90.69 | $87.64 | 681,400 | |
| $89.32 | -2.07 | -2.3% | $91.31 | $91.50 | $87.87 | 739,100 | |
| $91.39 | -0.61 | -0.7% | $92.49 | $92.82 | $90.55 | 775,200 | |
| $92.00 | +0.17 | +0.2% | $93.07 | $94.57 | $91.04 | 685,100 | |
| $91.83 | -6.99 | -7.1% | $98.76 | $98.76 | $91.73 | 1,798,000 | |
| $98.82 | +1.45 | +1.5% | $99.53 | $100.50 | $97.26 | 937,600 | |
| $97.37 | +3.47 | +3.7% | $93.95 | $98.83 | $93.76 | 991,200 | |
| $93.90 | -2.85 | -2.9% | $97.57 | $97.57 | $93.57 | 948,700 | |
| $96.75 | -1.47 | -1.5% | $98.37 | $100.00 | $96.54 | 488,400 | |
| $98.22 | -2.39 | -2.4% | $102.78 | $103.28 | $97.80 | 441,100 | |
| $100.61 | +2.31 | +2.3% | $98.30 | $101.18 | $97.48 | 586,900 | |
| $98.30 | -1.23 | -1.2% | $98.02 | $101.50 | $97.01 | 521,800 | |
| $99.53 | -1.37 | -1.4% | $98.49 | $101.83 | $97.65 | 638,500 | |
| $100.90 | +0.27 | +0.3% | $99.08 | $101.99 | $99.08 | 351,000 | |
| $100.63 | +0.80 | +0.8% | $101.56 | $101.73 | $99.06 | 453,000 | |
| $99.83 | +1.49 | +1.5% | $98.95 | $101.00 | $97.66 | 495,500 | |
| $98.34 | +0.29 | +0.3% | $97.84 | $99.69 | $97.47 | 398,400 | |
| $98.05 | +0.59 | +0.6% | $97.46 | $98.40 | $95.61 | 419,800 | |
| $97.46 | -2.29 | -2.3% | $99.43 | $100.06 | $96.55 | 426,500 | |
| $99.75 | +1.24 | +1.3% | $97.94 | $100.10 | $96.01 | 402,100 | |
| $98.51 | +0.43 | +0.4% | $97.95 | $98.80 | $95.00 | 571,100 | |
| $98.08 | +1.36 | +1.4% | $98.50 | $100.20 | $95.00 | 472,294 | |
| $96.72 | +0.41 | +0.4% | $96.31 | $97.85 | $95.49 | 367,573 | |
| $96.31 | -0.76 | -0.8% | $97.65 | $97.89 | $95.24 | 731,700 | |
| $97.07 | -5.17 | -5.1% | $100.73 | $101.96 | $96.98 | 352,500 | |
| $102.24 | +1.37 | +1.4% | $102.50 | $104.66 | $101.54 | 556,300 | |
| $100.87 | +1.04 | +1.0% | $99.50 | $101.26 | $99.00 | 518,100 | |
| $99.83 | -0.81 | -0.8% | $99.93 | $101.43 | $99.23 | 407,600 | |
| $100.64 | +1.87 | +1.9% | $98.03 | $101.31 | $96.73 | 503,800 | |
| $98.77 | -0.20 | -0.2% | $99.23 | $100.48 | $98.50 | 734,900 | |
| $98.97 | +0.74 | +0.8% | $98.30 | $100.37 | $98.30 | 649,600 | |
| $98.23 | -0.47 | -0.5% | $98.58 | $101.02 | $97.51 | 579,000 | |
| $98.70 | -1.95 | -1.9% | $99.58 | $100.57 | $97.41 | 868,000 | |
| $100.65 | +6.535 | +6.9% | $94.95 | $101.64 | $94.25 | 850,700 | |
| $94.12 | -11.68 | -11.0% | $90.25 | $97.00 | $88.88 | 2,969,300 |
- Ticker
- BIVA:MIRM
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- BIVA
- Currency
- MXN
What changed lately
Latest news release · Nov 3, 2026
Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Latest earnings call · Nov 3, 2026
Mirum Pharmaceuticals (NASDAQ:MIRM) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Oct 12, 2026
Corporate Update (October 2026)
Corporate update · 13 slides
Calls
Replays
Mirum Pharmaceuticals (NASDAQ:MIRM) Q3 2026 Earnings Call
Tue, Nov 03, 2026 · 4:30 PM ET
Watch TranscriptMirum Pharmaceuticals (NASDAQ:MIRM) Q2 2026 Earnings Call
Wed, Aug 05, 2026 · 4:30 PM ET
Watch TranscriptMirum Pharmaceuticals (NASDAQ:MIRM) Q1 2026 Earnings Call
Wed, May 06, 2026 · 4:30 PM ET
Watch Transcript
Latest news
Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
Nov 3, 2026
Closed $96.97 (+11.4%) on Nov 4, 2026
Mirum Pharmaceuticals Showcases Momentum Across Rare Liver Disease Portfolio with New Data at AASLD’s The Liver Meeting® 2026
Nov 2, 2026
Closed $85.74 (+0.9%) on Nov 2, 2026
Mirum Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 3, 2026
Oct 27, 2026
Closed $85.81 (+0.3%) on Oct 28, 2026
Mirum Pharmaceuticals Announces Positive Results from Cohort 2 of the Pivotal PROGRESS Study of ATEBRIOZ™ (zilurgisertib) in Pediatric Patients Aged 6 to <12 Years with Fibrodysplasia Ossificans Progressiva
Oct 26, 2026
Closed $83.27 (+3.6%) on Oct 26, 2026
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Oct 21, 2026
Closed $83.10 (-0.4%) on Oct 22, 2026
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 15, 2026
Closed $80.14 (-2.7%) on Oct 16, 2026
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 EXPAND Study of LIVMARLI® (maralixibat) in Ultra-Rare Cholestatic Liver Diseases
Oct 12, 2026
Closed $86.06 (+0.1%) on Oct 12, 2026
Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 3 AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus
Sep 28, 2026
Closed $87.96 (-1.9%) on Sep 28, 2026
Financings
Private placement of common stock and pre-funded warrants
Jan 26, 2026
Closed: US$200M raised · US$68.48 a share · Morgan Stanley & Co. LLC +4
Dealers: Morgan Stanley & Co. LLC, Leerink Partners LLC, Cantor Fitzgerald & Co., Raymond James & Associates, Inc., Citizens JMP Securities, LLC
Use of proceeds: To support clinical development and commercial activities following the acquisition of brelovitug in HDV
Private placement of common stock
Jan 26, 2026
Closed: US$68.5M raised · US$68.48 a share
Buyers: TCGX (1,000,000 shares of common stock)
Use of proceeds: To support clinical development and commercial activities following the acquisition of brelovitug in HDV
Decks
Corporate Update (October 2026)
Corporate update · 13 slides · Oct 12, 2026
Corporate Update (September 2026)
Corporate update · 11 slides · Sep 28, 2026
Technical Presentation (June 2026)
Technical · 6 slides · Jun 12, 2026
Corporate Update (May 2026)
Corporate update · 20 slides · May 4, 2026
Mirum Pharmaceuticals, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 40 in the last 12 months · 206 in all · newest Nov 3, 2026 · oldest 2019
- Calls
- 21 calls with a replay · 21 with a transcript · latest Nov 3, 2026
- Decks
- 27 decks · latest Oct 12, 2026
Where Mirum Pharmaceuticals, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MIRM · Home listing | NASDAQ | United States | USD |
| Tradegate:08D | Tradegate | Germany | EUR |
| gettex:08D | gettex | Germany | EUR |
| Lang & Schwarz:A2PM29 | Lang & Schwarz | Germany | EUR |
| Dusseldorf:08D | Dusseldorf | Germany | EUR |
| LS Exchange:A2PM29 | LS Exchange | Germany | EUR |
| BMV:MIRM | BMV | Mexico | MXN |
| Frankfurt:08D | Frankfurt | Germany | EUR |
| BIVA:MIRM · This page | BIVA | Mexico | MXN |
| BOATS:MIRM | BOATS | United States | USD |
| Hamburg:08D | Hamburg | Germany | EUR |
| Munich:08D | Munich | Germany | EUR |
| Stuttgart:08D | Stuttgart | Germany | EUR |
| Hanover:08D | Hanover | Germany | EUR |
| Xetra:08D | Xetra | Germany | EUR |
Log in to ask 6ix AI your own questions about Mirum Pharmaceuticals, Inc.